首页 > 最新文献

American Journal of Obstetrics & Gynecology Mfm最新文献

英文 中文
Adjunctive azithromycin for scheduled cesarean delivery in patients with obesity: a secondary analysis of a randomized controlled trial 肥胖症患者计划剖宫产时辅助使用阿奇霉素:随机对照试验的二次分析。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-31 DOI: 10.1016/j.ajogmf.2024.101454
{"title":"Adjunctive azithromycin for scheduled cesarean delivery in patients with obesity: a secondary analysis of a randomized controlled trial","authors":"","doi":"10.1016/j.ajogmf.2024.101454","DOIUrl":"10.1016/j.ajogmf.2024.101454","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fragility of statistically significant outcomes in obstetric randomized trials 产科随机试验中具有统计学意义的结果的脆弱性。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-31 DOI: 10.1016/j.ajogmf.2024.101449
{"title":"Fragility of statistically significant outcomes in obstetric randomized trials","authors":"","doi":"10.1016/j.ajogmf.2024.101449","DOIUrl":"10.1016/j.ajogmf.2024.101449","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to Editor regarding “Randomized trial of screening for preterm birth in low-risk women—the preterm birth screening study” 致编辑的信,内容涉及 "低风险妇女早产筛查随机试验--早产筛查研究"。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-31 DOI: 10.1016/j.ajogmf.2024.101438
{"title":"Letter to Editor regarding “Randomized trial of screening for preterm birth in low-risk women—the preterm birth screening study”","authors":"","doi":"10.1016/j.ajogmf.2024.101438","DOIUrl":"10.1016/j.ajogmf.2024.101438","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141879619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal outcomes by mode of delivery among pregnant patients with eclampsia: a retrospective cohort study 子痫孕妇的分娩方式对产妇预后的影响:一项回顾性队列研究。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-30 DOI: 10.1016/j.ajogmf.2024.101444
{"title":"Maternal outcomes by mode of delivery among pregnant patients with eclampsia: a retrospective cohort study","authors":"","doi":"10.1016/j.ajogmf.2024.101444","DOIUrl":"10.1016/j.ajogmf.2024.101444","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between interpregnancy interval and adverse perinatal outcomes among subsequent twin pregnancies: a nationwide population-based study 双胎妊娠的孕间隔与围产期不良结局之间的关系:一项基于全国人口的研究
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-28 DOI: 10.1016/j.ajogmf.2024.101439

Background

The existing evidence on the association between interpregnancy interval (IPI) and pregnancy outcomes primarily focuses on singleton pregnancies, with limited research on twin pregnancies.

Objective

This study aimed to investigate the association between IPI and adverse perinatal outcomes in twin pregnancies.

Study Design

This population-based, retrospective cohort study analyzed data from the National Center for Health Statistics in the United States between 2016 and 2020. We included multiparous women aged 18 to 45 years with live-born twins without congenital anomalies, born between 26 and 42 weeks of gestation. Poisson regression models, adjusted for potential confounders, were used to evaluate the associations between IPI and adverse outcomes, including preterm birth (PTB) <36 weeks, small for gestational age (SGA), neonatal intensive care unit (NICU) admission, neonatal composite morbidity, and infant death. Missing data on covariates were managed using multiple imputations. Dose-response analyses were performed using the restricted cubic splines (RCS) approach. Subgroup analyses were stratified by maternal age, parity, and combination of neonatal sex. Sensitivity analyses were conducted using complete data and excluding pregnancies with intervening events during the IPI.

Results

A total of 143,014 twin pregnancies were included in the analysis. Compared to the referent group (IPI of 18–23 months), an IPI of less than 6 months was associated with an increased risk of PTB<36 weeks (RR, 1.21; 95% confidence interval [95% CI]: 1.17–1.25), SGA (RR, 1.11; 95% CI: 1.03–1.18), neonatal composite morbidity (RR, 1.19; 95% CI: 1.12–1.27), NICU admission (RR, 1.18; 95% CI: 1.14–1.22), and infant death (RR, 1.29; 95% CI: 1.05–1.60). An IPI of 5 years or more was associated with an increased risk of PTB<36 weeks (RR, 1.18; 95% CI: 1.15–1.21), SGA (RR, 1.24; 95% CI: 1.18–1.30), neonatal composite morbidity (RR, 1.10; 95% CI: 1.05–1.15), and NICU admission (RR, 1.14; 95% CI: 1.11–1.17). The dose-response analyses showed that these outcomes had U-shaped or J-shaped associations with IPI. The associations between IPI and the outcomes slightly differed by advanced maternal age, parity, and combination of neonatal sex. The sensitivity analyses yielded similar results to the main findings.

Conclusion

Extreme IPI, less than 6 months or more than 5 years, was associated with adverse outcomes in twin pregnancies. IPI could be used as a predictor for risk stratification in high-risk twin pregnancies.

研究设计这项基于人群的回顾性队列研究分析了美国国家卫生统计中心在 2016 年至 2020 年间的数据。我们纳入了年龄在 18 到 45 岁之间、在妊娠 26 到 42 周之间出生的活产双胞胎且无先天性畸形的多产妇。在对潜在混杂因素进行调整后,我们使用泊松回归模型来评估 IPI 与不良结局之间的关系,包括早产 (PTB) <36 周、胎龄小 (SGA)、入住新生儿重症监护室 (NICU)、新生儿综合发病率和婴儿死亡。协变量的缺失数据采用多重推定法进行处理。剂量-反应分析采用限制性立方样条(RCS)方法进行。亚组分析按产妇年龄、奇偶数和新生儿性别组合进行分层。使用完整数据进行了敏感性分析,并排除了在 IPI 期间发生干预事件的孕妇。与参照组(IPI 为 18-23 个月)相比,IPI 不足 6 个月与 PTB<36 周(RR,1.21;95% 置信区间 [95%CI]:1.17-1.25)、SGA(RR,1.21;95% 置信区间 [95%CI]:1.17-1.25)风险增加有关。25)、SGA(RR,1.11;95% CI:1.03-1.18)、新生儿综合发病率(RR,1.19;95% CI:1.12-1.27)、入住新生儿重症监护室(RR,1.18;95% CI:1.14-1.22)和婴儿死亡(RR,1.29;95% CI:1.05-1.60)。5 年或以上的 IPI 与 PTB<36 周(RR,1.18;95% CI:1.15-1.21)、SGA(RR,1.24;95% CI:1.18-1.30)、新生儿综合发病率(RR,1.10;95% CI:1.05-1.15)和入住新生儿重症监护室(RR,1.14;95% CI:1.11-1.17)的风险增加有关。剂量-反应分析表明,这些结果与 IPI 呈 U 型或 J 型关系。高龄产妇、奇偶数和新生儿性别组合与 IPI 之间的关系略有不同。结论IPI过高(小于6个月或大于5年)与双胎妊娠的不良结局有关。IPI可作为高风险双胎妊娠风险分层的预测指标。
{"title":"Association between interpregnancy interval and adverse perinatal outcomes among subsequent twin pregnancies: a nationwide population-based study","authors":"","doi":"10.1016/j.ajogmf.2024.101439","DOIUrl":"10.1016/j.ajogmf.2024.101439","url":null,"abstract":"<div><h3>Background</h3><p>The existing evidence on the association between interpregnancy interval (IPI) and pregnancy outcomes primarily focuses on singleton pregnancies, with limited research on twin pregnancies.</p></div><div><h3>Objective</h3><p>This study aimed to investigate the association between IPI and adverse perinatal outcomes in twin pregnancies.</p></div><div><h3>Study Design</h3><p>This population-based, retrospective cohort study analyzed data from the National Center for Health Statistics in the United States between 2016 and 2020. We included multiparous women aged 18 to 45 years with live-born twins without congenital anomalies, born between 26 and 42 weeks of gestation. Poisson regression models, adjusted for potential confounders, were used to evaluate the associations between IPI and adverse outcomes, including preterm birth (PTB) &lt;36 weeks, small for gestational age (SGA), neonatal intensive care unit (NICU) admission, neonatal composite morbidity, and infant death. Missing data on covariates were managed using multiple imputations. Dose-response analyses were performed using the restricted cubic splines (RCS) approach. Subgroup analyses were stratified by maternal age, parity, and combination of neonatal sex. Sensitivity analyses were conducted using complete data and excluding pregnancies with intervening events during the IPI.</p></div><div><h3>Results</h3><p>A total of 143,014 twin pregnancies were included in the analysis. Compared to the referent group (IPI of 18–23 months), an IPI of less than 6 months was associated with an increased risk of PTB&lt;36 weeks (RR, 1.21; 95% confidence interval [95% CI]: 1.17–1.25), SGA (RR, 1.11; 95% CI: 1.03–1.18), neonatal composite morbidity (RR, 1.19; 95% CI: 1.12–1.27), NICU admission (RR, 1.18; 95% CI: 1.14–1.22), and infant death (RR, 1.29; 95% CI: 1.05–1.60). An IPI of 5 years or more was associated with an increased risk of PTB&lt;36 weeks (RR, 1.18; 95% CI: 1.15–1.21), SGA (RR, 1.24; 95% CI: 1.18–1.30), neonatal composite morbidity (RR, 1.10; 95% CI: 1.05–1.15), and NICU admission (RR, 1.14; 95% CI: 1.11–1.17). The dose-response analyses showed that these outcomes had U-shaped or J-shaped associations with IPI. The associations between IPI and the outcomes slightly differed by advanced maternal age, parity, and combination of neonatal sex. The sensitivity analyses yielded similar results to the main findings.</p></div><div><h3>Conclusion</h3><p>Extreme IPI, less than 6 months or more than 5 years, was associated with adverse outcomes in twin pregnancies. IPI could be used as a predictor for risk stratification in high-risk twin pregnancies.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589933324001654/pdfft?md5=3db893687ba198d3d720ee81594601f1&pid=1-s2.0-S2589933324001654-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141849262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remote blood pressure management for postpartum hypertension: a cost-effectiveness analysis 产后高血压的远程血压管理:成本效益分析。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-27 DOI: 10.1016/j.ajogmf.2024.101442

BACKGROUND

Recognizing the importance of close follow-up after hypertensive disorders of pregnancy, many centers have initiated programs to support postpartum remote blood pressure management.

OBJECTIVE

This study aimed to evaluate the cost-effectiveness of remote blood pressure management to determine the scalability of these programmatic interventions.

STUDY DESIGN

This was a cost-effectiveness analysis of using remote blood pressure management vs usual care to manage postpartum hypertension. The modeled remote blood pressure management included provision of a home blood pressure monitor, guidance on warning symptoms, instructions on blood pressure self-monitoring twice daily, and clinical staff to manage population-level blood pressures as appropriate. Usual care was defined as guidance on warning symptoms and recommendations for 1 outpatient visit for blood pressure monitoring within a week after discharge. This study designed a Markov model that ran over fourteen 1-day cycles to reflect the initial 2 weeks after delivery when most emergency department visits and readmissions occur and remote blood pressure management is clinically anticipated to be most impactful. Parameter values for the base-case scenario were derived from both internal data and literature review. Quality-adjusted life-years were calculated over the first year after delivery and reflected the short-term morbidities associated with hypertensive disorders of pregnancy that, for most birthing people, resolve by 2 weeks after delivery. Sensitivity analyses were performed to assess the strength and validity of the model. The primary outcome was the incremental cost-effectiveness ratio, which was defined as the cost needed to gain 1 quality-adjusted life-year. The secondary outcome was incremental cost per readmission averted. Analyses were performed from a societal perspective.

RESULTS

In the base-case scenario, remote blood pressure management was the dominant strategy (ie, cost less, higher quality-adjusted life-years). In univariate sensitivity analyses, the most cost-effective strategy shifted to usual care when the cost of readmission fell below $2987.92 and the rate of reported severe range blood pressure with a response in remote blood pressure management was <1%. Assuming a willingness to pay of $100,000 per quality-adjusted life-year, using remote blood pressure management was cost-effective in 99.28% of simulations in a Monte Carlo analysis. Using readmissions averted as a secondary effectiveness outcome, the incremental cost per readmission averted was $145.00.

CONCLUSION

Remote blood pressure management for postpartum hypertension is cost saving and has better outcomes than usual care. Our data can be used to inform future dissemination of and support funding for remote blood pressure management programs.

背景:认识到妊娠期高血压疾病(HDP)后密切随访的重要性,许多医疗中心都启动了产后远程血压管理(RBPM)项目:认识到妊娠期高血压疾病(HDP)后密切随访的重要性,许多中心已启动了支持产后远程血压管理(RBPM)的项目:研究设计:我们对利用 RBPM 管理产后高血压与常规护理进行了成本效益分析。示范 RBPM 包括提供家用血压计、关于预警症状的指导、每天两次的血压自我监测指导以及根据情况管理人群血压的临床人员。常规护理的定义是提供有关预警症状的指导,并建议患者在出院后一周内到门诊进行一次血压监测。我们设计了一个马尔可夫模型,该模型运行了 14 个为期一天的周期,以反映产后最初两周的情况,这两周是大多数急诊室就诊和再入院发生的时间,临床上预计 RBPM 的影响最大。基础方案的参数值来自内部数据和文献综述。产后第一年的 QALY 计算反映了与 HDP 相关的短期发病率,对于大多数分娩者来说,这些发病率在产后两周内就会消除。为评估模型的强度和有效性,进行了敏感性分析。主要结果是增量成本效益比 (ICER),定义为获得一个质量调整生命年 (QALY) 所需的成本。次要结果是每次避免再入院的增量成本。从社会角度进行了分析:在基础方案中,使用 RBPM 是最主要的策略(即成本更低、质量调整生命年更高)。在单变量敏感性分析中,当再入院费用低于 2,987.92 美元,且 RBPM 有反应的重度血压范围报告率低于 1%时,最具成本效益的策略将转向常规护理。假设每 QALY 的支付意愿为 100,000 美元,在蒙特卡罗分析中,99.28% 的模拟结果显示使用 RBPM 具有成本效益。将避免再入院作为次要有效性结果,每次避免再入院的增量成本为 145.00 美元:与常规护理相比,产后高血压的远程血压管理可节约成本并获得更好的疗效。这些数据可用于今后远程血压管理项目的推广和资金支持。
{"title":"Remote blood pressure management for postpartum hypertension: a cost-effectiveness analysis","authors":"","doi":"10.1016/j.ajogmf.2024.101442","DOIUrl":"10.1016/j.ajogmf.2024.101442","url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Recognizing the importance of close follow-up after hypertensive disorders of pregnancy, many centers have initiated programs to support postpartum remote blood pressure management.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to evaluate the cost-effectiveness of remote blood pressure management to determine the scalability of these programmatic interventions.</p></div><div><h3>STUDY DESIGN</h3><p>This was a cost-effectiveness analysis of using remote blood pressure management vs usual care to manage postpartum hypertension. The modeled remote blood pressure management included provision of a home blood pressure monitor, guidance on warning symptoms, instructions on blood pressure self-monitoring twice daily, and clinical staff to manage population-level blood pressures as appropriate. Usual care was defined as guidance on warning symptoms and recommendations for 1 outpatient visit for blood pressure monitoring within a week after discharge. This study designed a Markov model that ran over fourteen 1-day cycles to reflect the initial 2 weeks after delivery when most emergency department visits and readmissions occur and remote blood pressure management is clinically anticipated to be most impactful. Parameter values for the base-case scenario were derived from both internal data and literature review. Quality-adjusted life-years were calculated over the first year after delivery and reflected the short-term morbidities associated with hypertensive disorders of pregnancy that, for most birthing people, resolve by 2 weeks after delivery. Sensitivity analyses were performed to assess the strength and validity of the model. The primary outcome was the incremental cost-effectiveness ratio, which was defined as the cost needed to gain 1 quality-adjusted life-year. The secondary outcome was incremental cost per readmission averted. Analyses were performed from a societal perspective.</p></div><div><h3>RESULTS</h3><p>In the base-case scenario, remote blood pressure management was the dominant strategy (ie, cost less, higher quality-adjusted life-years). In univariate sensitivity analyses, the most cost-effective strategy shifted to usual care when the cost of readmission fell below $2987.92 and the rate of reported severe range blood pressure with a response in remote blood pressure management was &lt;1%. Assuming a willingness to pay of $100,000 per quality-adjusted life-year, using remote blood pressure management was cost-effective in 99.28% of simulations in a Monte Carlo analysis. Using readmissions averted as a secondary effectiveness outcome, the incremental cost per readmission averted was $145.00.</p></div><div><h3>CONCLUSION</h3><p>Remote blood pressure management for postpartum hypertension is cost saving and has better outcomes than usual care. Our data can be used to inform future dissemination of and support funding for remote blood pressure management programs.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258993332400168X/pdfft?md5=c22ceb467a311416fccb136b762b37df&pid=1-s2.0-S258993332400168X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Venous vs capillary glucose for gestational diabetes screening: a comparative study 静脉葡萄糖与毛细血管葡萄糖用于妊娠糖尿病筛查的比较研究:比较研究。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-27 DOI: 10.1016/j.ajogmf.2024.101443
{"title":"Venous vs capillary glucose for gestational diabetes screening: a comparative study","authors":"","doi":"10.1016/j.ajogmf.2024.101443","DOIUrl":"10.1016/j.ajogmf.2024.101443","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postpartum hospital readmissions. Blood pressure is only one piece of the puzzle 产后再入院。血压只是拼图的一部分。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-27 DOI: 10.1016/j.ajogmf.2024.101437
{"title":"Postpartum hospital readmissions. Blood pressure is only one piece of the puzzle","authors":"","doi":"10.1016/j.ajogmf.2024.101437","DOIUrl":"10.1016/j.ajogmf.2024.101437","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and ethnic disparities in patient education on postpartum warning signs 产后预警信号患者教育中的种族和民族差异。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-27 DOI: 10.1016/j.ajogmf.2024.101441
{"title":"Racial and ethnic disparities in patient education on postpartum warning signs","authors":"","doi":"10.1016/j.ajogmf.2024.101441","DOIUrl":"10.1016/j.ajogmf.2024.101441","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis 产前造影显示胎盘早剥可能性高的孕妇的紧急分娩:系统回顾和荟萃分析。
IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-26 DOI: 10.1016/j.ajogmf.2024.101432
<div><h3>BACKGROUND</h3><p>Placenta accreta spectrum disorders are associated with a high risk of maternal morbidity, particularly when surgery is performed under emergency conditions. This study aimed to investigate the incidence of emergency cesarean delivery in patients with a high probability of placenta accreta spectrum disorders on prenatal imaging and to compare the maternal and neonatal outcomes between patients requiring emergency cesarean delivery and those not requiring emergency cesarean delivery.</p></div><div><h3>DATA SOURCES</h3><p>MEDLINE, Embase, Cochrane, and ClinicalTrials.gov databases were searched.</p></div><div><h3>STUDY ELIGIBILITY CRITERIA</h3><p>This study included case-control studies reporting the outcomes of pregnancies with a high probability of placenta accreta spectrum on prenatal imaging confirmed at birth delivered via unplanned emergency cesarean delivery vs those delivered via planned elective cesarean delivery for maternal or fetal indications. The outcomes observed were the occurrence of emergency cesarean delivery; incidence of placenta accreta and placenta increta/placenta percreta; preterm birth at <34 weeks of gestation; and indications for emergency delivery. This study analyzed and compared the outcomes between patients who underwent emergency cesarean delivery and those who underwent elective cesarean delivery, including estimated blood loss; number of packed red blood cell units transfused and blood products transfused; transfusion of more than 4 units of packed red blood cell; ureteral, bladder, or bowel injury; disseminated intravascular coagulation; relaparotomy after the primary surgery; maternal infection or fever; wound infection; vesicouterine or vesicovaginal fistula; admission to the neonatal intensive care unit; maternal death; composite neonatal morbidity; fetal or neonatal loss; Apgar score of <7 at 5 minutes; and neonatal birthweight.</p></div><div><h3>METHODS</h3><p>Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale for case-control and cohort studies. Random-effect meta-analyses of proportions, risks, and mean differences were used to combine the data.</p></div><div><h3>RESULTS</h3><p>A total of 11 studies with 1290 pregnancies complicated by placenta accreta spectrum were included in the systematic review. Emergency cesarean delivery was reported in 36.2% of pregnancies (95% confidence interval, 28.1–44.9) with placenta accreta spectrum at birth, of which 80.3% of cases (95% confidence interval, 36.5–100.0) occurred before 34 weeks of gestation. The main indication for emergency cesarean delivery was antepartum bleeding, which complicated 61.8% of the cases (95% confidence interval, 32.1–87.4). Patients who underwent emergent cesarean delivery had higher estimated blood loss during surgery (pooled mean difference, 595 mL; 95% confidence interval, 116.10–1073.90; <em>P</em><.001), higher number of packed red blood cells transfused (pooled
背景:胎盘早剥谱系(PAS)疾病与孕产妇发病率的高风险相关,尤其是在紧急情况下进行手术时。在此背景下,我们旨在报告产前影像学检查发现胎盘早剥谱系(PAS)疾病可能性高的患者中急诊剖宫产(CS)的发生率,并比较需要与不需要急诊剖宫产的患者的孕产妇和新生儿结局:检索了 Medline、Embase、Cochrane 和 Clinicaltrial.gov 数据库:研究资格标准:病例对照研究,报告因母体或胎儿原因而进行计划外急诊CS与计划内择期CS相比,产前造影证实PAS可能性高的孕妇在出生时的结局。我们观察到的结果包括急诊CS的发生率、胎盘早剥和胎盘增厚/早剥的发生率、妊娠期小于34周的早产率以及急诊分娩的指征。我们分析并比较了急诊CS患者与择期CS患者的结果,包括估计失血量(EBL)(毫升)、输注的包装红细胞(PRBC)单位数和输注的血液制品、输注超过 4 个单位的 PRBC 输尿管、膀胱或肠道损伤、弥散性血管内凝血(DIC)、初次手术后再次进行腹腔镜手术、孕产妇感染或发热、伤口感染、膀胱阴道瘘或膀胱阴道瘘、入住新生儿重症监护室、孕产妇死亡、新生儿综合发病率、入住新生儿重症监护室、胎儿或新生儿死亡、5 分钟内 Apgar 评分小于 7 分、新生儿出生体重。研究评估和综合方法:采用纽卡斯尔-渥太华量表对病例对照和队列研究进行质量评估:系统综述共纳入了 11 项研究,涉及 1290 例 PAS 并发症妊娠。据报道,36.2%(95% CI 28.1-44.9)的妊娠在出生时出现 PAS,其中 80.3%(95% CI 36.5-100)的妊娠在妊娠 34 周前发生急诊手术。产前出血是紧急剖宫产的主要指征,61.8%(95% CI 32.1-87.4)的病例因此而复杂化。与计划进行的CS相比,急诊CS患者在手术期间输注的EBL(汇集MD 595毫升,95% CI 116.1-1073.9,p< 0.001)、PRBC(汇集MD 2.3单位,95% CI 0.99-3.6,p< 0.001)和血制品(汇集MD 3.0,95% CI 1.1-4.9,p= 0.002)更高。急诊CS患者需要输注4个单位以上PRBC的风险更高(OR:3.8,95% CI 1.7-4.9;p= 0.002),膀胱损伤(OR:2.1,95% CI 1.1-4.00;p= 0.003)、DIC(OR 6.1,95% CI 3.1-13.1;p结论:约有 35% 的妊娠因 PAS 疾病而导致急诊 CD 并发症,并与较高的孕产妇和新生儿不良预后风险相关。需要进行大型前瞻性研究,以评估临床和影像学体征,从而确定哪些患者在出生时很可能患有 PAS,需要进行急诊剖宫产、产时出血和围产期子宫切除术。
{"title":"Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis","authors":"","doi":"10.1016/j.ajogmf.2024.101432","DOIUrl":"10.1016/j.ajogmf.2024.101432","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;BACKGROUND&lt;/h3&gt;&lt;p&gt;Placenta accreta spectrum disorders are associated with a high risk of maternal morbidity, particularly when surgery is performed under emergency conditions. This study aimed to investigate the incidence of emergency cesarean delivery in patients with a high probability of placenta accreta spectrum disorders on prenatal imaging and to compare the maternal and neonatal outcomes between patients requiring emergency cesarean delivery and those not requiring emergency cesarean delivery.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;DATA SOURCES&lt;/h3&gt;&lt;p&gt;MEDLINE, Embase, Cochrane, and ClinicalTrials.gov databases were searched.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;STUDY ELIGIBILITY CRITERIA&lt;/h3&gt;&lt;p&gt;This study included case-control studies reporting the outcomes of pregnancies with a high probability of placenta accreta spectrum on prenatal imaging confirmed at birth delivered via unplanned emergency cesarean delivery vs those delivered via planned elective cesarean delivery for maternal or fetal indications. The outcomes observed were the occurrence of emergency cesarean delivery; incidence of placenta accreta and placenta increta/placenta percreta; preterm birth at &lt;34 weeks of gestation; and indications for emergency delivery. This study analyzed and compared the outcomes between patients who underwent emergency cesarean delivery and those who underwent elective cesarean delivery, including estimated blood loss; number of packed red blood cell units transfused and blood products transfused; transfusion of more than 4 units of packed red blood cell; ureteral, bladder, or bowel injury; disseminated intravascular coagulation; relaparotomy after the primary surgery; maternal infection or fever; wound infection; vesicouterine or vesicovaginal fistula; admission to the neonatal intensive care unit; maternal death; composite neonatal morbidity; fetal or neonatal loss; Apgar score of &lt;7 at 5 minutes; and neonatal birthweight.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;METHODS&lt;/h3&gt;&lt;p&gt;Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale for case-control and cohort studies. Random-effect meta-analyses of proportions, risks, and mean differences were used to combine the data.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;RESULTS&lt;/h3&gt;&lt;p&gt;A total of 11 studies with 1290 pregnancies complicated by placenta accreta spectrum were included in the systematic review. Emergency cesarean delivery was reported in 36.2% of pregnancies (95% confidence interval, 28.1–44.9) with placenta accreta spectrum at birth, of which 80.3% of cases (95% confidence interval, 36.5–100.0) occurred before 34 weeks of gestation. The main indication for emergency cesarean delivery was antepartum bleeding, which complicated 61.8% of the cases (95% confidence interval, 32.1–87.4). Patients who underwent emergent cesarean delivery had higher estimated blood loss during surgery (pooled mean difference, 595 mL; 95% confidence interval, 116.10–1073.90; &lt;em&gt;P&lt;/em&gt;&lt;.001), higher number of packed red blood cells transfused (pooled ","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Obstetrics & Gynecology Mfm
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1